NCT01337752View on ClinicalTrials.gov

Study in Patients With Untreated Multiple Myeloma and Renal Insufficiency

PHASE2CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Multiple MyelomaRenal Insufficiency
Interventions
DRUG

BHQ880

DRUG

BHQ880 Placebo

Intravenous infusion

DRUG

bortezomib

intravenous injection

DRUG

dexamethasone

Oral

Trial Locations (8)

28006

Novartis Investigative Site, Madrid

46026

Novartis Investigative Site, Valencia

60637

University Chicago Hospital Dept. of Univ of Chicago (2), Chicago

99208

Medical Oncology Associates, PS, Spokane

BH7 7DW

Novartis Investigative Site, Bournemouth

M13 9WL

Novartis Investigative Site, Manchester

OX3 7LJ

Novartis Investigative Site, Oxford

SO16 6YD

Novartis Investigative Site, Southampton

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY